User profiles for Bruce Kirenga

Bruce Kirenga

Chief Research Scientist and Director Makerere University Lung Institute
Verified email at chs.mak.ac.ug
Cited by 1464

Association between household air pollution exposure and chronic obstructive pulmonary disease outcomes in 13 low-and middle-income country settings

…, A Bernabe-Ortiz, D Alam, B Kirenga… - American journal of …, 2018 - atsjournals.org
Rationale: Forty percent of households worldwide burn biomass fuels for energy, which may
be the most important contributor to household air pollution. Objectives: To examine the …

[HTML][HTML] The health and social implications of household air pollution and respiratory diseases

…, C Roa, ME Crocker, GE Gianella, BJ Kirenga… - NPJ primary care …, 2019 - nature.com
Approximately three billion individuals are exposed to household air pollution (HAP) from
the burning of biomass fuels worldwide. Household air pollution is responsible for 2.9 million …

[HTML][HTML] International research and guidelines on post-tuberculosis chronic lung disorders: a systematic scoping review

…, A Wanner, M Edwards, AD Harries, BJ Kirenga… - BMJ global …, 2018 - gh.bmj.com
Introduction Pulmonary tuberculosis (TB) is an important risk factor for chronic respiratory
disease due to residual lung damage. Yet, the WHO End TB strategy does not mention post-TB …

[HTML][HTML] Prevalence and factors associated with asthma among adolescents and adults in Uganda: a general population based survey

BJ Kirenga, C de Jong, W Katagira, S Kasozi… - BMC public health, 2019 - Springer
Background Recent large-scale population data on the prevalence of asthma and its risk
factors are lacking in Uganda. This survey was conducted to address this data gap. Methods A …

ARIA‐EAACI statement on asthma and COVID‐19 (June 2, 2020)

…, N Ilina, JC Ivancevich, G Joos, M Khaitov, B Kirenga… - Allergy, 2021 - Wiley Online Library
To the Editor, A novel strain of human coronaviruses, the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), named by the International Committee on Taxonomy of …

[HTML][HTML] Elucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencing

…, D Harris, S Ogwang, F Mumbowa, B Kirenga… - PloS one, 2013 - journals.plos.org
Background Understanding the emergence and spread of multidrug-resistant tuberculosis (MDR-TB)
is crucial for its control. MDR-TB in previously treated patients is generally …

National tuberculosis prevalence surveys in Africa, 2008–2016: an overview of results and lessons learned

…, L Kendall, H Kipruto, BJ Kirenga… - Tropical Medicine & …, 2020 - Wiley Online Library
Objective and methods Worldwide, tuberculosis (TB) is the leading cause of death from a
single infectious agent. In many countries, national TB prevalence surveys are the only way to …

[HTML][HTML] Prednisolone and Mycobacterium indicus pranii in Tuberculous Pericarditis

…, B Brown, P Manga, B Kirenga… - … England Journal of …, 2014 - Mass Medical Soc
Background Tuberculous pericarditis is associated with high morbidity and mortality even if
antituberculosis therapy is administered. We evaluated the effects of adjunctive …

[HTML][HTML] Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional …

F van Gemert, B Kirenga, N Chavannes… - The Lancet Global …, 2015 - thelancet.com
Background In sub-Saharan Africa, little is known about the damage to respiratory health
caused by biomass smoke and tobacco smoke. We assessed the prevalence of chronic …

[HTML][HTML] Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised …

…, CY Chiang, F Conradie, M Gurumurthy, B Kirenga… - The Lancet, 2022 - thelancet.com
Background The STREAM stage 1 trial showed that a 9-month regimen for the treatment of
rifampicin-resistant tuberculosis was non-inferior to the 20-month 2011 WHO-recommended …